pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-378c |
Genomic Coordinates | chr10: 130962588 - 130962668 |
Description | Homo sapiens miR-378c stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-378c | ||||||||||||||||||||||||
Sequence | 11| ACUGGACUUGGAGUCAGAAGAGUGG |35 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TGFB2 | ||||||||||||||||||||
Synonyms | G-TSF, LDS4, TGF-beta2 | ||||||||||||||||||||
Description | transforming growth factor beta 2 | ||||||||||||||||||||
Transcript | NM_001135599 | ||||||||||||||||||||
Other Transcripts | NM_003238 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TGFB2 | |||||||||||||||||||||
3'UTR of TGFB2 (miRNA target sites are highlighted) |
>TGFB2|NM_001135599|3'UTR 1 AATTCTTGGAAAAGTGGCAAGACCAAAATGACAATGATGATGATAATGATGATGACGACGACAACGATGATGCTTGTAAC 81 AAGAAAACATAAGAGAGCCTTGGTTCATCAGTGTTAAAAAATTTTTGAAAAGGCGGTACTAGTTCAGACACTTTGGAAGT 161 TTGTGTTCTGTTTGTTAAAACTGGCATCTGACACAAAAAAAGTTGAAGGCCTTATTCTACATTTCACCTACTTTGTAAGT 241 GAGAGAGACAAGAAGCAAATTTTTTTTAAAGAAAAAAATAAACACTGGAAGAATTTATTAGTGTTAATTATGTGAACAAC 321 GACAACAACAACAACAACAACAAACAGGAAAATCCCATTAAGTGGAGTTGCTGTACGTACCGTTCCTATCCCGCGCCTCA 401 CTTGATTTTTCTGTATTGCTATGCAATAGGCACCCTTCCCATTCTTACTCTTAGAGTTAACAGTGAGTTATTTATTGTGT 481 GTTACTATATAATGAACGTTTCATTGCCCTTGGAAAATAAAACAGGTGTATAAAGTGGAGACCAAATACTTTGCCAGAAA 561 CTCATGGATGGCTTAAGGAACTTGAACTCAAACGAGCCAGAAAAAAAGAGGTCATATTAATGGGATGAAAACCCAAGTGA 641 GTTATTATATGACCGAGAAAGTCTGCATTAAGATAAAGACCCTGAAAACACATGTTATGTATCAGCTGCCTAAGGAAGCT 721 TCTTGTAAGGTCCAAAAACTAAAAAGACTGTTAATAAAAGAAACTTTCAGTCAGAATAAGTCTGTAAGTTTTTTTTTTTC 801 TTTTTAATTGTAAATGGTTCTTTGTCAGTTTAGTAAACCAGTGAAATGTTGAAATGTTTTGACATGTACTGGTCAAACTT 881 CAGACCTTAAAATATTGCTGTATAGCTATGCTATAGGTTTTTTCCTTTGTTTTGGTATATGTAACCATACCTATATTATT 961 AAAATAGATGGATATAGAAGCCAGCATAATTGAAAACACATCTGCAGATCTCTTTTGCAAACTATTAAATCAAAACATTA 1041 ACTACTTTATGTGTAATGTGTAAATTTTTACCATATTTTTTATATTCTGTAATAATGTCAACTATGATTTAGATTGACTT 1121 AAATTTGGGCTCTTTTTAATGATCACTCACAAATGTATGTTTCTTTTAGCTGGCCAGTACTTTTGAGTAAAGCCCCTATA 1201 GTTTGACTTGCACTACAAATGCATTTTTTTTTTAATAACATTTGCCCTACTTGTGCTTTGTGTTTCTTTCATTATTATGA 1281 CATAAGCTACCTGGGTCCACTTGTCTTTTCTTTTTTTTGTTTCACAGAAAAGATGGGTTCGAGTTCAGTGGTCTTCATCT 1361 TCCAAGCATCATTACTAACCAAGTCAGACGTTAACAAATTTTTATGTTAGGAAAAGGAGGAATGTTATAGATACATAGAA 1441 AATTGAAGTAAAATGTTTTCATTTTAGCAAGGATTTAGGGTTCTAACTAAAACTCAGAATCTTTATTGAGTTAAGAAAAG 1521 TTTCTCTACCTTGGTTTAATCAATATTTTTGTAAAATCCTATTGTTATTACAAAGAGGACACTTCATAGGAAACATCTTT 1601 TTCTTTAGTCAGGTTTTTAATATTCAGGGGGAAATTGAAAGATATATATTTTAGTCGATTTTTCAAAAGGGGAAAAAAGT 1681 CCAGGTCAGCATAAGTCATTTTGTGTATTTCACTGAAGTTATAAGGTTTTTATAAATGTTCTTTGAAGGGGAAAAGGCAC 1761 AAGCCAATTTTTCCTATGATCAAAAAATTCTTTCTTTCCTCTGAGTGAGAGTTATCTATATCTGAGGCTAAAGTTTACCT 1841 TGCTTTAATAAATAATTTGCCACATCATTGCAGAAGAGGTATCCTCATGCTGGGGTTAATAGAATATGTCAGTTTATCAC 1921 TTGTCGCTTATTTAGCTTTAAAATAAAAATTAATAGGCAAAGCAATGGAATATTTGCAGTTTCACCTAAAGAGCAGCATA 2001 AGGAGGCGGGAATCCAAAGTGAAGTTGTTTGATATGGTCTACTTCTTTTTTGGAATTTCCTGACCATTAATTAAAGAATT 2081 GGATTTGCAAGTTTGAAAACTGGAAAAGCAAGAGATGGGATGCCATAATAGTAAACAGCCCTTGTGTTGGATGTAACCCA 2161 ATCCCAGATTTGAGTGTGTGTTGATTATTTTTTTGTCTTCCACTTTTCTATTATGTGTAAATCACTTTTATTTCTGCAGA 2241 CATTTTCCTCTCAGATAGGATGACATTTTGTTTTGTATTATTTTGTCTTTCCTCATGAATGCACTGATAATATTTTAAAT 2321 GCTCTATTTTAAGATCTCTTGAATCTGTTTTTTTTTTTTTTAATTTGGGGGTTCTGTAAGGTCTTTATTTCCCATAAGTA 2401 AATATTGCCATGGGAGGGGGGTGGAGGTGGCAAGGAAGGGGTGAAGTGCTAGTATGCAAGTGGGCAGCAATTATTTTTGT 2481 GTTAATCAGCAGTACAATTTGATCGTTGGCATGGTTAAAAAATGGAATATAAGATTAGCTGTTTTGTATTTTGATGACCA 2561 ATTACGCTGTATTTTAACACGATGTATGTCTGTTTTTGTGGTGCTCTAGTGGTAAATAAATTATTTCGATGATATGTGGA 2641 TGTCTTTTTCCTATCAGTACCATCATCGAGTCTAGAAAACACCTGTGATGCAATAAGACTATCTCAAGCTGGAAAAGTCA 2721 TACCACCTTTCCGATTGCCCTCTGTGCTTTCTCCCTTAAGGACAGTCACTTCAGAAGTCATGCTTTAAAGCACAAGAGTC 2801 AGGCCATATCCATCAAGGATAGAAGAAATCCCTGTGCCGTCTTTTTATTCCCTTATTTATTGCTATTTGGTAATTGTTTG 2881 AGATTTAGTTTCCATCCAGCTTGACTGCCGACCAGAAAAAATGCAGAGAGATGTTTGCACCATGCTTTGGCTTTCTGGTT 2961 CTATGTTCTGCCAACGCCAGGGCCAAAAGAACTGGTCTAGACAGTATCCCCTGTAGCCCCATAACTTGGATAGTTGCTGA 3041 GCCAGCCAGATATAACAAGAGCCACGTGCTTTCTGGGGTTGGTTGTTTGGGATCAGCTACTTGCCTGTCAGTTTCACTGG 3121 TACCACTGCACCACAAACAAAAAAACCCACCCTATTTCCTCCAATTTTTTTGGCTGCTACCTACAAGACCAGACTCCTCA 3201 AACGAGTTGCCAATCTCTTAATAAATAGGATTAATAAAAAAAGTAATTGTGACTCAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293S |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084065. RNA binding protein: AGO2. Condition:CLIP_emetine_AbnovaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_003238 | 3UTR | UCCAGGUCAGCAUAAGUCAUUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1084065 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_AbnovaAb |
Location of target site | ENST00000366930.4 | 3UTR | AAAAGGGGAAAAAAGUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
32 hsa-miR-378c Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT052829 | DDX17 | DEAD-box helicase 17 | 1 | 1 | ||||||||
MIRT052830 | RPS7 | ribosomal protein S7 | 1 | 1 | ||||||||
MIRT052831 | SEC31A | SEC31 homolog A, COPII coat complex component | 1 | 1 | ||||||||
MIRT052832 | KDM8 | lysine demethylase 8 | 1 | 1 | ||||||||
MIRT052833 | ANO4 | anoctamin 4 | 1 | 1 | ||||||||
MIRT463104 | ZNF609 | zinc finger protein 609 | 2 | 2 | ||||||||
MIRT469375 | REST | RE1 silencing transcription factor | 2 | 6 | ||||||||
MIRT495444 | KCNJ6 | potassium voltage-gated channel subfamily J member 6 | 2 | 2 | ||||||||
MIRT513609 | VPS37B | VPS37B, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT520417 | TXNL1 | thioredoxin like 1 | 2 | 4 | ||||||||
MIRT525114 | PRKD2 | protein kinase D2 | 2 | 2 | ||||||||
MIRT525982 | SPA17 | sperm autoantigenic protein 17 | 2 | 2 | ||||||||
MIRT527005 | ARL8B | ADP ribosylation factor like GTPase 8B | 2 | 2 | ||||||||
MIRT529218 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT529838 | ARGFX | arginine-fifty homeobox | 2 | 2 | ||||||||
MIRT532302 | HAUS3 | HAUS augmin like complex subunit 3 | 2 | 2 | ||||||||
MIRT537579 | ESYT2 | extended synaptotagmin 2 | 2 | 2 | ||||||||
MIRT543143 | AKT1 | AKT serine/threonine kinase 1 | 2 | 2 | ||||||||
MIRT554927 | RAP1B | RAP1B, member of RAS oncogene family | 2 | 2 | ||||||||
MIRT564973 | WTAP | WT1 associated protein | 2 | 2 | ||||||||
MIRT570119 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | 2 | 2 | ||||||||
MIRT652737 | TGFB2 | transforming growth factor beta 2 | 2 | 2 | ||||||||
MIRT655951 | NDST1 | N-deacetylase and N-sulfotransferase 1 | 2 | 2 | ||||||||
MIRT656000 | MYRF | myelin regulatory factor | 2 | 2 | ||||||||
MIRT684878 | P4HB | prolyl 4-hydroxylase subunit beta | 2 | 2 | ||||||||
MIRT692972 | LGSN | lengsin, lens protein with glutamine synthetase domain | 2 | 2 | ||||||||
MIRT693740 | ACACA | acetyl-CoA carboxylase alpha | 2 | 2 | ||||||||
MIRT710994 | PPARGC1B | PPARG coactivator 1 beta | 2 | 2 | ||||||||
MIRT712242 | RCC2 | regulator of chromosome condensation 2 | 2 | 2 | ||||||||
MIRT718605 | DCTPP1 | dCTP pyrophosphatase 1 | 2 | 2 | ||||||||
MIRT723502 | WDR33 | WD repeat domain 33 | 2 | 2 | ||||||||
MIRT725450 | HIPK3 | homeodomain interacting protein kinase 3 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|